Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.

Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM.

Ann Neurol. 1987 Mar;21(3):307-10.

PMID:
3300518
2.

Clonidine treatment of Gilles de la Tourette's syndrome.

Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ.

Arch Gen Psychiatry. 1991 Apr;48(4):324-8.

PMID:
2009034
3.

Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective.

Leckman JF, Detlor J, Harcherik DF, Ort S, Shaywitz BA, Cohen DJ.

Neurology. 1985 Mar;35(3):343-51.

PMID:
3883235
4.

The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.

Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB.

Pediatrics. 1995 Jan;95(1):74-81.

PMID:
7770313
5.

Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics.

Shapiro AK, Shapiro E, Eisenkraft GJ.

Arch Gen Psychiatry. 1983 Nov;40(11):1235-40.

PMID:
6139100
6.

A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data.

Goetz CG, Tanner CM, Wilson RS, Shannon KM.

Neurology. 1987 Sep;37(9):1542-4.

PMID:
3476860
7.

The autonomic nervous system in Gilles de la Tourette's syndrome.

Goetz CG, Shannon KM, Carroll VS, Tanner CM, Weingarten R.

Mov Disord. 1987;2(2):99-102.

PMID:
2904121
8.

Clonidine in Gilles de la Tourette's syndrome.

Roos RA, Minderaa RB, Cohen AP, Van de Wetering BJ, Van Woerkom TC.

Ann Neurol. 1987 Dec;22(6):773-4. No abstract available.

PMID:
3324950
9.

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.

Müller-Vahl KR, Schneider U, Koblenz A, Jöbges M, Kolbe H, Daldrup T, Emrich HM.

Pharmacopsychiatry. 2002 Mar;35(2):57-61.

PMID:
11951146
10.

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.

Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA.

Arch Gen Psychiatry. 1989 Aug;46(8):722-30.

PMID:
2665687
11.

Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome.

Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S.

Neurology. 2003 Oct 14;61(7):936-40.

PMID:
14557563
12.

Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.

Hedderick EF, Morris CM, Singer HS.

Pediatr Neurol. 2009 Jun;40(6):420-5. doi: 10.1016/j.pediatrneurol.2008.12.014.

PMID:
19433274
13.

On the use of clonidine and thioproperazine in a woman with Gilles de la Tourette's disease.

Lechin F, van der Dijs B, Gómez F, Acosta E, Arocha L.

Biol Psychiatry. 1982 Jan;17(1):103-8.

PMID:
6120723
14.

[Control of inner speech and Gilles de la Tourette's syndrome].

Vercueil L.

Encephale. 2003 Sep-Oct;29(5):460-2. French.

PMID:
14615696
15.

[Gilles de la Tourette's syndrome].

Damjanović A, Kostić VS, Sternić N.

Srp Arh Celok Lek. 1992 May-Jun;120(5-6):197-202. Serbian.

PMID:
1465677
16.

Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.

Goetz CG, Stebbins GT, Thelen JA.

Mov Disord. 1994 May;9(3):315-7.

PMID:
7913738
17.

Beneficial effects of imipramine on Tourette's syndrome.

Sandyk R, Bamford CR.

Int J Neurosci. 1988 Mar;39(1-2):27-9.

PMID:
3164308
18.

The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder.

Cath DC, Spinhoven P, van de Wetering BJ, Hoogduin CA, Landman AD, van Woerkom TC, Roos RA, Rooijmans HG.

J Clin Psychiatry. 2000 Jul;61(7):505-13.

PMID:
10937609
19.
20.

Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.

Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA.

J Clin Psychiatry. 2001 Jan;62(1):50-6.

PMID:
11235929

Supplemental Content

Support Center